These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 10428423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist.
    Cumberbatch MJ, Williamson DJ, Mason GS, Hill RG, Hargreaves RJ.
    Br J Pharmacol; 1999 Mar; 126(6):1478-86. PubMed ID: 10217543
    [Abstract] [Full Text] [Related]

  • 6. The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation.
    Cutrer FM, Moussaoui S, Garret C, Moskowitz MA.
    Neuroscience; 1995 Feb; 64(3):741-50. PubMed ID: 7536309
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system.
    Amrutkar DV, Ploug KB, Hay-Schmidt A, Porreca F, Olesen J, Jansen-Olesen I.
    Pain; 2012 Apr; 153(4):830-838. PubMed ID: 22305629
    [Abstract] [Full Text] [Related]

  • 11. Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633.
    McCall RB, Huff R, Chio CL, TenBrink R, Bergh CL, Ennis MD, Ghazal NB, Hoffman RL, Meisheri K, Higdon NR, Hall E.
    Cephalalgia; 2002 Dec; 22(10):799-806. PubMed ID: 12485205
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
    Buzzi MG, Moskowitz MA, Peroutka SJ, Byun B.
    Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
    Martin GR, Robertson AD, MacLennan SJ, Prentice DJ, Barrett VJ, Buckingham J, Honey AC, Giles H, Moncada S.
    Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
    [Abstract] [Full Text] [Related]

  • 17. Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis.
    Mitsikostas DD, Sanchez del Rio M, Moskowitz MA, Waeber C.
    Eur J Pharmacol; 1999 Mar 26; 369(3):271-7. PubMed ID: 10225363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.
    Cutrer FM, Schoenfeld D, Limmroth V, Panahian N, Moskowitz MA.
    Br J Pharmacol; 1995 Mar 26; 114(5):987-92. PubMed ID: 7780655
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.
    Shepherd SL, Williamson DJ, Beer MS, Hill RG, Hargreaves RJ.
    Neuropharmacology; 1997 Mar 26; 36(4-5):525-33. PubMed ID: 9225277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.